Phase 2 Shigella Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
The Impact of Shigellosis and Recommended Treatment in Children
ShigellaDiarrhea InfectiousGrowth & Development
Johns Hopkins Bloomberg School of Public Health700 enrolled4 locationsNCT07433426
Recruiting
Phase 2
Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old
Shigella
Eveliqure Biotechnologies GmbH72 enrolled1 locationNCT07049159